Clinical trials: Subclinical Primary Aldosteronism, active
Subclinical Primary Aldosteronism
Early Aldo Blockade in Subclinical PA
This trial aims to evaluate the preventive effect of early intervention with eplerenone, a highly selective nonsteroidal mineralocorticoid receptor antagonist, against new-onset hypertension in normotensive patients with…
- Trial name
- EARLY-PA (NCT07727252)
- Testing
- Eplerenone
- Volunteers
- 880 people
- Sponsor
- Xinjiang Medical University
Type 2 Diabetes, Chronic Kidney Diseases
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
The aim of this protocol is to assess the presence and severity of primary aldosteronism pathophysiology in patients with type 2 diabetes who have, or are at-risk for developing, chronic kidney disease.
- Trial name
- SubPA-DKD (NCT06190158)
- Testing
- Oral sodium suppression test, Saline suppression test, Captopril suppression test
- Where
- United States
- Volunteers
- 125 people
- Sponsor
- Brigham and Women's Hospital